In connection with the implementation of the project entitled “Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids”, by BS Biotechna SA, under the agreement No. 2022/ABM/06/00005-00 for co-financing of a commercial project under the Competition for the development of targeted or personalized medicine based on medicinal products based on nucleic acids and compounds The Ordering Party conducts market research on the costs of purchasing tips
In order to submit an offer, please read the detailed content of the offer included in the “delivery” and send a completed offer form.